K Halbhübner, H Herken, D Loos. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » 6-Aminonicotinamide/adverse effectsAnimalsAntipsychotic Agents/pharmacologyBaclofen/pharmacologyBrain/metabolismBrain ChemistryBromocriptine/therapeutic useCentral Nervous System Diseases/chemically inducedDisease Models, AnimalDopamine/pharmacologyDrug Evaluation, PreclinicalElectromyographyGluconates/cerebrospinal fluidLevodopa/pharmacologyLevodopa/therapeutic useLisuride/therapeutic useMaleMotor Neurons/drug effectsMuscle Contraction/drug effectsNiacinamide/analogs & derivativesParkinson Disease, Secondary/chemically inducedParkinson Disease, Secondary/drug therapyParkinson Disease, Secondary/pathologyRNA/biosynthesisRatsReserpine/adverse effectsSpinal Cord/analysisSugar Phosphates/cerebrospinal fluid
Substances: See more » Antipsychotic AgentsGluconatesSugar PhosphatesNiacinamide6-AminonicotinamideBromocriptineLevodopaRNAReserpineLisurideBaclofenDopamine
Year: 1978 PMID: 39569
Source DB: PubMed Journal: Arzneimittelforschung ISSN: 0004-4172